Associated Banc Corp Sells 2,804 Shares of Danaher Corporation $DHR

Associated Banc Corp cut its stake in Danaher Corporation (NYSE:DHR) by 4.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 57,427 shares of the conglomerate’s stock after selling 2,804 shares during the quarter. Associated Banc Corp’s holdings in Danaher were worth $10,888,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in DHR. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at about $26,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher during the fourth quarter valued at about $27,000. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at about $25,000. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the last quarter. Finally, WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter worth approximately $26,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

NYSE DHR traded up $3.13 on Friday, reaching $199.11. 3,847,629 shares of the company’s stock traded hands, compared to its average volume of 3,706,558. The stock has a 50 day moving average price of $180.59 and a 200-day moving average price of $199.48. The firm has a market cap of $140.92 billion, a price-to-earnings ratio of 38.51, a P/E/G ratio of 2.54 and a beta of 0.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the firm posted $1.88 EPS. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. Equities research analysts predict that Danaher Corporation will post 8.44 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s payout ratio is presently 30.95%.

Analysts Set New Price Targets

DHR has been the topic of several research analyst reports. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a report on Friday, April 17th. Morgan Stanley cut their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, UBS Group lowered their price target on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $231.64.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.